Other OTC - Delayed Quote USD

Shengtai Pharmaceutical, Inc. (SGTI)

0.0000 0.0000 (0.00%)
At close: December 11 at 12:03 PM EST
Loading Chart for SGTI
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0000
  • Volume 85,385
  • Avg. Volume 85,385
  • Market Cap (intraday) --
  • Beta (5Y Monthly) -1.27
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Shengtai Pharmaceutical, Inc., through its subsidiaries, engages in the manufacture and distribution of glucose and starch products in the People's Republic of China and internationally. The company provides pharmaceutical and medical grade products, including dextrose monohydrate, dextrose anhydrous, dextrin, and pharmaceutical grade cornstarch; and rough glucose, dextrose monohydrate oral, and food and beverage grade cornstarch for the food and beverage, and processing industries. It also offers other products comprising fibers, corn embryo, protein powder, mother liquid, and abamectin ointment. The company markets its products directly to healthcare institutions, medical supply companies, pharmaceutical companies, medical supply exporters, and food and beverage companies. Shengtai Pharmaceutical, Inc. was incorporated in 2004 and is based in Weifang, China.

--

Full Time Employees

June 30

Fiscal Year Ends

--

Sector

--

Industry

Related News

Performance Overview: SGTI

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SGTI
0.00%
MSCI WORLD
4.98%

1-Year Return

SGTI
--
MSCI WORLD
8.85%

3-Year Return

SGTI
--
MSCI WORLD
8.85%

5-Year Return

SGTI
--
MSCI WORLD
8.85%

Compare To: SGTI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SGTI

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.70%

  • Return on Assets (ttm)

    1.59%

  • Return on Equity (ttm)

    -2.42%

  • Revenue (ttm)

    221.39M

  • Net Income Avi to Common (ttm)

    -1.55M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    38.1M

  • Total Debt/Equity (mrq)

    283.82%

  • Levered Free Cash Flow (ttm)

    -50.92M

Research Analysis: SGTI

Analyst Price Targets

 

Earnings

Consensus EPS
 

Company Insights: SGTI